Alterations in brain monoamine oxidase activity in aging, Alzheimer's disease, and Pick's disease.
about
Drug Development in Alzheimer's Disease: The Contribution of PET and SPECTTyrosine hydroxylase and Parkinson's diseaseConsensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.Effects of depression, cigarette smoking, and age on monoamine oxidase B in amygdaloid nuclei.Presenile dementia syndromes: an update on taxonomy and diagnosis.Medical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategiesA systematic review of neurotransmitter deficits and treatments in frontotemporal dementia.The human pineal gland and melatonin in aging and Alzheimer's disease.Elevated Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and CognitionPlatelets: A possible glance into brain biological processes in schizophrenia.Pharmacogenomic implications of variants of monoaminergic-related genes in geriatric psychiatry.Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.Selegiline reverses aβ₂₅₋₃₅-induced cognitive deficit in male mice.Effects of Coeloglossum. viride var. bracteatum extract on memory deficits and pathological changes in senescent mice.Neurotransmitter deficits from frontotemporal lobar degeneration.Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease.Melatonin and the Prevention and Management of Delirium: A Scoping Study.
P2860
Q26749755-9754C8A7-C3A0-4F40-A6BB-A2F0C800C292Q28273702-F070D59C-4FDC-4DE3-9C8C-37FBB9846B66Q33223171-E7D5340B-E46E-4167-B1F6-E73F5B0D1E0AQ34064063-772E6440-9CEF-45C0-99CA-F4384536B488Q34649249-0186A49B-BDD9-4712-BB38-37E8B2611110Q35523924-F425EA56-2B50-4F42-9CA3-D449740C292AQ35844609-DA86F09A-3D9B-41D4-AB87-A424162E98E5Q36051556-8D74A702-4233-4CA1-9A68-46E0CD7F4474Q37088430-D1B10600-994B-4126-82B6-3116DF5221EDQ37195343-3D335406-D43D-4C32-81EE-F59240FE2E8BQ37791156-7659422E-6E25-42D6-A345-59F7CF969C0EQ38391397-886C1F47-7D54-406B-A854-29E2811C97EAQ43643813-69A8BE98-1D85-4411-BB38-502E2059CF95Q46909426-7D651AFA-FC28-49DB-94FB-3E8ADEAEAD0BQ47837913-6D44D83C-FEF2-4223-BE23-548CCD65FD29Q47999645-A106FA0B-39AB-412C-8E38-D8F9CA94E481Q49444379-397674CE-A9D9-44FA-A905-CF3F86AFA897
P2860
Alterations in brain monoamine oxidase activity in aging, Alzheimer's disease, and Pick's disease.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Alterations in brain monoamine ...... s disease, and Pick's disease.
@en
Alterations in brain monoamine ...... s disease, and Pick's disease.
@nl
type
label
Alterations in brain monoamine ...... s disease, and Pick's disease.
@en
Alterations in brain monoamine ...... s disease, and Pick's disease.
@nl
prefLabel
Alterations in brain monoamine ...... s disease, and Pick's disease.
@en
Alterations in brain monoamine ...... s disease, and Pick's disease.
@nl
P2093
P1433
P1476
Alterations in brain monoamine ...... s disease, and Pick's disease.
@en
P2093
Markesbery WR
P304
P356
10.1001/ARCHNEUR.1991.00530190064017
P577
1991-07-01T00:00:00Z